-
Article
Open AccessCRNDE acts as an epigenetic modulator of the p300/YY1 complex to promote HCC progression and therapeutic resistance
Hepatocellular carcinoma (HCC) is one of the most common primary liver malignancies worldwide. The long-term prognosis for HCC remains extremely poor, with drug resistance being the major underlying cause of r...
-
Article
Open AccessIFITM3 promotes malignant progression, cancer stemness and chemoresistance of gastric cancer by targeting MET/AKT/FOXO3/c-MYC axis
Targeting the HGF/MET signaling pathway has been a viable therapeutic strategy for various cancer types due to hyperactivation of HGF/MET axis occurs frequently that leads to detrimental cancer progression and...
-
Article
Real time prediction of closing price and duration of B2B reverse auctions
Nowadays, online auctions have become the most successful business model in the electronic marketplace. To the best of the authors’ knowledge, no other work has been devoted to the prediction of closing price ...